Search the Newsreel

Global Indemnity Group Q2 Results: Earnings call set for Aug 5

MNTN (MNTN) Expected to Post Quarterly Earnings on Tuesday

Vuzix (VUZI) investor group led by AIGH discloses 6.7M-share stake

An investor group led by AIGH Capital Management LLC has disclosed an 8.1% stake in Vuzix Corporation (VUZI), holding 6,745,667 shares of common stock. The filing, a Schedule 13G, indicates that AIGH Capital Management LLC, AIGH Investment Partners LLC, and Orin Hirschman collectively possess …

Enterprise value to EBIT forward of OmniAb, Inc. – NASDAQ:OABI

This article focuses on the enterprise value to EBIT forward for OmniAb, Inc. (NASDAQ:OABI). It indicates that financial data for this metric is provided by FactSet Research Systems Inc. and market data by ICE Data Services.

(OMC) and the Role of Price-Sensitive Allocations

This article provides an in-depth analysis of Omnicom Group Inc. (NYSE: OMC) focusing on price-sensitive allocations, neutral sentiment, and potential trading strategies. It highlights an exceptional risk-reward short setup and offers AI-generated signals and institutional trading strategies for various risk profiles. The analysis suggests …

Amneal Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:AMRX

OMC Looks 12.9% Undervalued on GF Value™ Heading into Q2 Earnings

Omnicom Group Inc (NYSE: OMC) is preparing to announce its second-quarter earnings, with analysts forecasting significant increases in EPS and revenue. GuruFocus' GF Value™ suggests the stock is modestly undervalued by 12.9%, despite a high trailing P/E ratio, while its GF Score™ of 83 …

AMN Healthcare Services Inc (AMN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of AMN Healthcare Services Inc (AMN), detailing its price momentum score of 3.58 and its trading range between a resistance of $36.20 and support of $30.78. It presents a breakdown of various technical indicators, such as MACD, RSI, …

Somnigroup Announces Refinancing of Credit Facilities

Somnigroup International Inc. announced the successful refinancing of its $2.9 billion senior secured credit facilities, including a $1.7 billion revolver and a $1.2 billion term loan A. This amendment lowers the company's cost of capital, extends debt maturities, and enhances financial flexibility. The transaction …

Veraxa Advances Bispecific ADC Candidate VXA-222 Following OmniAb Discovery Milestone

Veraxa Biotech has advanced its bispecific antibody-drug conjugate (ADC) program, VXA-222, into the next development phase after OmniAb completed its antibody discovery work. This collaboration utilizes OmniAb's transgenic antibody discovery platform and Veraxa’s proprietary ADC linker and conjugation technology to create a dual-antigen "AND-gate" …

VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

VERAXA Biotech (NASDAQ: VRXA) has advanced its bispecific antibody-drug conjugate (bsADC) program, VXA-222, reaching a key technical milestone in its collaboration with OmniAb (NASDAQ: OABI). OmniAb completed its discovery work, moving the program to its next phase. VXA-222 is designed to target two tumor …

AMN Healthcare Services Inc (AMN) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for AMN Healthcare Services Inc (AMN), detailing its volatility, financial, and investment risks. The company currently holds a risk assessment score of 5.69, positioning it at 35 out of 75 in the Healthcare Providers & Services industry. Key …

Omnicom Group Inc (OMC) Balance Sheet

This article provides a detailed balance sheet for Omnicom Group Inc (OMC), outlining quarterly and annual financial data across various asset, liability, and equity categories. It includes historical data dating back several years, showing trends in cash, receivables, total assets, total liabilities, and shareholders' …

How marketers can tackle a new creative paradigm with connected content

Marketers are facing a new creative paradigm called "connected content" due to media fragmentation, second screening, and AI. This model, proposed by Omnicom Media Intelligence, aims to integrate various channels like media, commerce, and creator marketing into content creation for more effective campaigns. It …

Erie Indemnity (ERIE) director gains 1.762 deferred compensation share credits

Erie Indemnity Company director William David Edwards acquired 1.762 Directors' Deferred Compensation Share Credits on July 21, 2026, through dividend reinvestment. These share credits represent the right to receive an equivalent number of Class A common shares upon the termination of his board service …

OABI|OmniAb Inc|Price:2.030|

OmniAb Inc. (OABI) licenses discovery research technology to pharmaceutical and biotech companies, leveraging its OmniAb platform to identify optimal antibodies for drug development. The company utilizes engineered transgenic animals like OmniRat and OmniChicken to generate human sequence antibodies. OmniAb's top five shareholders include Mr. …

Veraxa advances cancer therapy program with OmniAb

Veraxa Biotech AG announced that its bispecific antibody-drug conjugate program, VXA-222, advanced to the next development phase after completing discovery work with OmniAb, Inc. The program targets solid tumors using AND-gate logic, combining OmniAb's antibody discovery technologies with Veraxa's linker technology. Veraxa holds exclusive …

Amneal Pharmaceuticals, Inc. Class A Revenue Breakdown – FWB:2DT

Amneal Pharmaceuticals, Inc. Class A (FWB:2DT) generated 2.57 billion EUR last year, with its Affordable Medicines segment being the top performer contributing 1.49 billion EUR. The primary revenue sources by region were the United States, India, and Ireland. The company's total revenue saw a …

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

VERAXA Biotech announced the advancement of its bispecific ADC (bsADC) program VXA-222, developed in collaboration with OmniAb. This program, which uses an "AND-gate" logic to target solid tumors, has moved into its next phase following the successful completion of OmniAb's discovery work. VERAXA will …

ERIE|Erie Indemnity Co|Price:255.930|Chg%:+0.100

Omnicom Group Inc Revenue Breakdown – MIL:1OMC

Omnicom Group Inc. (MIL:1OMC) generated total revenue of €14.71 billion last year. Its top-performing segment, Media & Advertising, contributed €8.53 billion, an increase from €8.18 billion in the previous year. The United States was the largest geographical contributor, accounting for €7.75 billion, slightly down …

OmniAb Inc (OABI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for OmniAb Inc (OABI) across its business segments for various fiscal quarters and years. It highlights that the company's main revenue streams are service revenue, license and milestone revenue, royalty revenue, and xPloration revenue. The data is …

AMN Healthcare Services Inc (AMN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article provides a detailed revenue breakdown for AMN Healthcare Services Inc (AMN) across its various business segments and geographical regions. It highlights that in FY2025, Temporary Staffing accounted for the vast majority of revenue at 84.13% ($2.30 billion), with Technology-enabled services, Permanent Placement, …

SomnoMed Posts Record Half-Year Revenue and 35% EBITDA Lift, But FY26 Verdict Is Still to Come

SomnoMed Co-CEO Steps Down; Fiscal 2026 Revenue Misses Guidance

SomnoMed Director Amrita Singh Blickstead Exits Company After Shareholding Disposal

How Investors May Respond To Amneal Pharmaceuticals (AMRX) Expanding Its Iohexol Generic Portfolio Across OMNIPAQUE Formats

Amneal Pharmaceuticals has received FDA approval for additional strengths and vial sizes of its iohexol injection, making it the first generic supplier for various OMNIPAQUE-referenced presentations. This expansion reinforces Amneal's injectable and hospital portfolio, potentially supporting its revenue and earnings forecasts, but also highlights …

AMN Healthcare Services Inc (AMN) Cash Flow

This article provides a detailed cash flow statement for AMN Healthcare Services Inc (AMN), presenting quarterly and annual data for operating, investing, and financing activities. It includes year-over-year percentage changes for various cash flow components and explains the significance of operating, investing, and financing …

AMN Healthcare Services Inc - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance | TradingKey

This article provides a detailed company profile for AMN Healthcare Services Inc (AMN), a provider of healthcare talent solutions in the U.S. It covers the company's business segments, key financial figures like market cap and revenue, and lists important executive and board members. The …

Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Omnicell Inc (OMCL) currently has an earnings forecast score of 8.00, placing it 68th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $47.00, with a majority recommending a "Buy" trend for the stock. The company's expected revenue …

Omnicom Group (OMC) Q2 Earnings: What To Expect

Omnicom Group (OMC) Q2 Earnings: What To Expect Global advertising giant Omnicom Group (NYSE:OMC) will be announcing earnings results this Tuesday after market hours. Here's what investors should know. Omnicom Group beat analysts' revenue expectations last quarter, reporting revenues of $6.24 billion, up 69.2% …

AMN Healthcare Services, Inc. Revenue Breakdown – DUS:HCQ

This article provides a revenue breakdown for AMN Healthcare Services, Inc. (DUS:HCQ), detailing its top-performing segment, Nurse and Allied Solutions, which generated 1.40 billion EUR last year. The company's total revenue was 2.32 billion EUR, with the largest contribution coming from the United States.

OmniAb Inc (OABI) Balance Sheet

This article provides the quarterly and annual balance sheets for OmniAb Inc (OABI), allowing users to assess the company's financial health, fundamentals, and key financial ratios. It details assets, liabilities, and shareholders' equity over recent fiscal quarters and years, along with frequently asked questions …

Vuzix Corporation (0LRL) Q3 2022 Earnings Report - Results, Call & Slides

This article provides the Q3 2022 earnings report for Vuzix Corporation (0LRL), detailing actual EPS of -$0.15 (beating consensus) and actual revenue of $3.43M (beating expectations) with a 13.52% YoY growth. It includes details on the earnings announcement date, conference call, slide deck, and …

VUZI|Vuzix Corp|Price:2.290|Chg%:-0.010

This article provides a company profile for Vuzix Corp (VUZI), detailing its business in AI-powered Smart Glasses and AR technologies. It lists key financials, executive team, and shareholder information, noting that institutional shareholding increased in Q1 2026 and product sales are the largest revenue …

Omnicom Group stock trades steadily as revenue growth and margins support valuation

Omnicom Group stock demonstrates stable performance due to consistent revenue growth, strong margins, and shareholder-friendly capital allocation. The company, a major global advertising and marketing services provider, has shown year-over-year increases in revenue and net income, alongside solid EPS growth. This financial health supports …